News
QTRX
2.590
-9.44%
-0.270
Major Insider Move Signals Growing Confidence in Quanterix
TipRanks · 14h ago
Quanterix: The Market Was Right To Lose Patience (Rating Downgrade)
Seeking Alpha · 3d ago
Quanterix Price Target Cut to $3.00/Share From $4.00 by TD Cowen
Dow Jones · 4d ago
Quanterix Is Maintained at Hold by TD Cowen
Dow Jones · 4d ago
TD Cowen Maintains Hold on Quanterix, Lowers Price Target to $3
Benzinga · 4d ago
Quanterix price target lowered to $3 from $4 at TD Cowen
TipRanks · 4d ago
Quanterix: Hold Rating Reiterated as Guidance Cut Offsets Alzheimer’s Progress; $4 Price Target Maintained
TipRanks · 4d ago
Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), MoonLake Immunotherapeutics (MLTX) and Quanterix (QTRX)
TipRanks · 4d ago
Quanterix Warns of Broad Risk Exposure Despite No New Material Changes in Latest 10-Q
TipRanks · 4d ago
Quanterix Earnings Call: Guidance Cut Amid Margin Gains
TipRanks · 4d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 4d ago
Quanterix misses top-line and bottom-line estimates; updates FY26 outlook
Seeking Alpha · 5d ago
Quanterix appoints Gute as Chief Commercial Officer
TipRanks · 5d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 5d ago
Quanterix sees FY26 revenue $142M-$148M, consensus $169.86M
TipRanks · 5d ago
*Quanterix Sees FY26 Rev $142M-$148M >QTRX
Dow Jones · 5d ago
Press Release: Quanterix Releases Financial Results for the Second Quarter of 2026
Dow Jones · 5d ago
Press Release: Quanterix Releases Financial -2-
Dow Jones · 5d ago
*Quanterix 2Q Rev $32.9M >QTRX
Dow Jones · 5d ago
Weekly Report: what happened at QTRX last week (0803-0807)?
Weekly Report · 5d ago
More
Webull provides a variety of real-time QTRX stock news. You can receive the latest news about Quanterix through multiple platforms. This information may help you make smarter investment decisions.
About QTRX
Quanterix Corporation is a life sciences company. The Company is focused on ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development proprietary digital Simoa detection technology enables customers to reliably detect protein biomarkers at ultra-low concentrations in blood, serum and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies. Its Simoa bead-based digital immunoassays utilize the basic principles of conventional bead-based sandwich ELISA. The HD-X is the Company's flagship instrument that empowers biomarker research and accelerates drug development. Its SR-X instrument is a compact benchtop instrument with a lower price point, more flexible assay preparation, and a wider range of applications. The Company's Spatial Biology solutions measure protein expression and cellular phenotypes within intact tissue while preserving spatial context and tissue architecture.